1. Home
  2. YOU vs WVE Comparison

YOU vs WVE Comparison

Compare YOU & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Secure Inc.

YOU

Clear Secure Inc.

HOLD

Current Price

$34.76

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$13.79

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YOU
WVE
Founded
2010
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
YOU
WVE
Price
$34.76
$13.79
Analyst Decision
Buy
Strong Buy
Analyst Count
7
16
Target Price
$38.43
$29.94
AVG Volume (30 Days)
1.3M
4.1M
Earning Date
02-25-2026
03-03-2026
Dividend Yield
2.21%
N/A
EPS Growth
88.46
N/A
EPS
1.62
N/A
Revenue
$866,298,000.00
$109,230,000.00
Revenue This Year
$17.42
N/A
Revenue Next Year
$12.53
$16.20
P/E Ratio
$21.57
N/A
Revenue Growth
17.83
103.75
52 Week Low
$21.67
$5.28
52 Week High
$42.29
$21.73

Technical Indicators

Market Signals
Indicator
YOU
WVE
Relative Strength Index (RSI) 46.41 45.52
Support Level $33.25 $13.72
Resistance Level $36.86 $15.97
Average True Range (ATR) 1.15 1.33
MACD -0.23 -0.54
Stochastic Oscillator 42.88 5.62

Price Performance

Historical Comparison
YOU
WVE

About YOU Clear Secure Inc.

Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: